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Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine sound, and migraine with aura, which is characterized by transient visual, sensory, or speech symptoms usually followed by a headache phase similar to migraine without aura.
Family and twin studies estimate a heritability of 42% (95% confidence interval = 36-47%) for migraine 7 , pointing to a genetic component of the disease. Despite this, genetic association studies have uncovered relatively little about the molecular mechanisms that contribute to migraine's pathophysiology. Understanding has been limited partly because so far only 13 genome-wide significant risk loci have been identified for the prevalent forms of migraine [8] [9] [10] [11] . For familial hemiplegic migraine (FHM), a rare Mendelian form of the disease, three ion-transport-related genes (CACNA1A, ATP1A2, and SCN1A) have been implicated [12] [13] [14] . These findings suggest that mechanisms that regulate neuronal ion homeostasis might also be involved in migraine more generally; however, no genes related to ion transport have yet been identified for the more prevalent forms of migraine 15 .
We conducted a meta-analysis of 22 GWA studies, including data for a total of 59,674 affected subjects and 316,078 controls collected from six tertiary headache clinics and 27 population-based cohorts through our worldwide collaboration with the International Headache Genetics Consortium (IHGC). This combined data set contained more than 35,000 new migraine cases not included in previously published GWA studies. Here we present the findings of this meta-analysis, including 38 genomic loci harboring 44 independent association signals identified at levels of genome-wide significance, which support current theories of migraine pathophysiology and also offer new insights into the disease.
RESULTS

Significant associations at 38 independent genomic loci
The primary meta-analysis was carried out on all samples from subjects with migraine available through the IHGC, regardless of ascertainment. These case samples came from both individuals diagnosed by a doctor and individuals with self-reported migraine as stated on questionnaires. Study design and sample ascertainment for each individual study are outlined in the Supplementary Note (and summarized in Supplementary Table 1) . The final combined sample consisted of 59,674 case samples and 316,078 controls in 22 non-overlapping case-control data sets ( Table 1 ). All subjects were of European ancestry (EUR). Before including the largest study from 23andMe, we confirmed that it did not contribute any additional heterogeneity compared with the other population and clinic-based studies (Supplementary Table 2 ).
The 22 individual GWA studies included standard quality control protocols (Online Methods), summarized in Supplementary Table 3 . Missing genotypes were then imputed into each sample using a common 1000 Genomes Project reference panel 16 . Association analyses were carried out within each study using logistic regression on the imputed marker dosages, with adjustments made for sex and other covariates where necessary (Online Methods and Supplementary Table 4 ). The association results were combined in an inverse-variance weighted fixed-effects meta-analysis. Markers were filtered for imputation quality and other metrics (Online Methods), leaving 8,094,889 variants for consideration in our primary analysis.
Among the variants in the primary analysis, we identified 44 genome-wide significant SNP associations (P < 5 × 10 −8 ; Supplementary Fig. 1 ) that were independent (r 2 < 0.1) with regard to linkage disequilibrium (LD). We validated these 44 SNPs by comparing genotypes in a subset of the sample to those obtained from whole-genome sequencing (Supplementary Table 5 ). To help identify candidate risk genes, we defined an associated locus as the genomic region bounded by all markers in LD (r 2 > 0.6 in 1000 Genomes Project, phase 1, EUR individuals) with each of the 44 index SNPs, and in addition, all such regions in close proximity (<250 kb) were merged. On the basis of these defined regions, we implicated 38 genomic loci for the prevalent forms of migraine, 28 of which had not been reported previously (Fig. 1) .
These 38 loci replicated 10 of the 13 previously reported genomewide associations with migraine, and 6 loci contained a secondary genome-wide significant SNP not in LD (r 2 < 0.1) with the top SNP in the locus ( Table 2) . Five of these secondary signals were found in known loci (at LRP1-STAT6-SDR9C7, PRDM16, FHL5-UFL1, TRPM8-HJURP, and near TSPAN2-NGF), whereas the sixth was found within one of the 28 new loci (PLCE1). Therefore, out of the 44 independent SNPs reported here, 34 represent new associations with migraine. Three previously reported loci that were associated with subtypes of migraine (rs1835740 near MTDH for migraine with aura, rs10915437 near AJAP1 for migraine clinical samples, and rs10504861 near MMP16 for migraine without aura) 8, 11 showed only nominal significance in the current meta-analysis (P = 5 × 10 −3 for rs1835740, P = 4.4 × 10 −5 for rs10915437, and P = 4.9 × 10 −5 for rs10504861; Supplementary Table 6) ; however, these loci have since been shown to be associated with specific phenotypic features of migraine 17 , and therefore a more phenotypically homogeneous sample may be required for an accurate assessment of association. Four out of 44 SNPs (MRVI1, at TRPM8-HJURP, near ZCCHC14, and near CCM2L-HCK) showed moderate heterogeneity across the individual GWA studies (Cochran's Q test, P < 0.05; Supplementary Table 7) ; therefore, at these markers we applied a random-effects model 18 .
Characterization of the associated loci
In total, 32 of 38 (84%) loci overlapped with transcripts from proteincoding genes, and 17 (45%) of these regions contained just a single gene (see Supplementary Fig. 2 for regional association plots and Supplementary Table 8 for additional locus information). Among the 38 loci, only two contained ion channel genes (KCNK5 and TRPM8) 19, 20 . Thus, despite previous hypotheses that migraine is a potential channelopathy 5, 21 , the loci identified to date do not support the idea of common variants in ion channel genes being strong susceptibility components in prevalent forms of migraine. However, three other loci do contain genes involved more generally in ion homeostasis [22] [23] [24] (SLC24A3, ITPK1, and GJA1; Supplementary Table 9) .
Several of the identified genes have previously been associated with vascular disease (PHACTR1, TGFBR2, LRP1, PRDM16, RNF213, JAG1, HEY2, GJA1, and ARMS2) [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] or are involved in smooth muscle contractility and regulation of vascular tone (MRVI1, GJA1, SLC24A3, and NRP1) [35] [36] [37] [38] . Three of the 44 migraine index SNPs had previously reported associations in the National Human Genome Research Institute GWA study catalog at exactly the same SNP (rs9349379 at PHACTR1 with coronary heart disease [39] [40] [41] , coronary artery calcification 42 , and cervical artery dissection 26 ; rs11624776 near ITPK1 with thyroid hormone levels 43 ; and rs11172113 at LRP1-STAT6-SDR9C7 with pulmonary function 44 ; Supplementary Table 10) . Six of the loci harbor genes that are involved in nitric oxide (NO) signaling and oxidative stress (REST, GJA1, YAP1, PRDM16, LRP1, and MRVI1) [45] [46] [47] [48] [49] [50] .
For each locus, we chose the gene nearest to the index SNP to assess gene expression activity in tissues from the Genotype-Tissue Expression (GTEx) Consortium project (Supplementary Fig. 3 ). Although we found that most of the putative migraine loci genes were expressed in many different tissue types, we were able to detect tissue specificity in certain instances in which some genes showed 8 5 8 VOLUME 48 | NUMBER 8 | AUGUST 2016 Nature GeNetics A r t i c l e s significantly higher expression in a particular tissue group relative to the others. For instance, four genes were expressed more actively in brain (GPR149, CFDP1, DOCK4, and MPPED2) than in other tissues, and eight genes were specifically active in vascular tissues (PRDM16, MEF2D, FHL5, C7orf10, YAP1, LRP1, ZCCHC14, and JAG1). Many other putative migraine loci genes were actively expressed in more than one tissue group.
Genomic inflation and LD-score regression analysis
To assess whether the 38 loci harbored true associations with migraine, rather than reflecting systematic differences between case and control samples (such as population stratification), we analyzed the genome-wide inflation of test statistics in our primary metaanalysis. As expected for a complex polygenic trait, the distribution of test statistics deviated from the null (genomic inflation factor λ GC = 1.24; Supplementary Fig. 4) , which is in line with other large GWA study meta-analyses [51] [52] [53] [54] . Because much of the inflation for a polygenic trait arises from LD between the causal SNPs and many other neighboring SNPs in the local region, we LD-pruned the data to create a set of LD-independent markers (in PLINK 55 with a 250-kb sliding window and r 2 > 0.2). The resulting genomic inflation was comparatively reduced (λ GC = 1.15; Supplementary 5 ) and probably reflects the inflation remaining owing to the polygenic signal at many independent loci, including those not yet significantly associated. To confirm that the observed inflation came primarily from true polygenic signal, we analyzed the data from all imputed markers using LD-score regression 56 . This method tests for a linear relationship between marker test statistics and LD score, defined as the sum of r 2 values between a marker and all other markers within a 1-Mb window. The primary analysis results show a linear relationship between association test statistics and LD score (Supplementary Fig. 6 ) and suggest that the majority (88.2%) of the inflation in test statistics can be ascribed to true polygenic signal rather than population stratification or other confounders. These results are consistent with the theory of polygenic disease architecture demonstrated previously by Ten loci were previously reported (PubMed IDs (PMID) are listed for these loci), and 28 were newly found in this study. Each locus is labeled with protein-coding genes that overlap the region. Intergenic loci are also labeled as "near" to highlight the additional uncertainty in identifying relevant genes. Effect sizes and P values for each SNP were calculated for each study with an additive genetic model using logistic regression adjusted for sex and then combined in a fixed-effects meta-analysis. For loci that contain a secondary LD-independent signal passing genome-wide significance, the secondary index SNP and P value are given. For the seven loci reaching genome-wide significance in the 'migraine without aura' subtype analysis, the corresponding index SNP and P value are also given. Evidence for significant heterogeneity was found at four loci (TRPM8-HJURP, MRVI1, near ZCCHC14, and near CCM2L-HCK), so for those we present the results of a random-effects model. Chr, chromosome; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval. A r t i c l e s GWA studies using samples of similar size with both simulated and real data 57 .
Migraine subtype analyses
To elucidate pathophysiological mechanisms underpinning the migraine aura, we carried out a secondary analysis of two created subsets that included only samples with the subtypes 'migraine with aura' and 'migraine without aura' . These subsets included samples only from studies in which sufficient information was available to assign a diagnosis of one or the other subtype according to classification criteria standardized by the International Headache Society 6 . For the population-based studies, this involved questionnaires, whereas for the clinic-based studies the diagnosis was assigned on the basis of a structured interview by telephone or in person. A stricter diagnosis was required for the migraine subtypes, as it is often challenging to distinguish migraine aura from other neurological features that can present as symptoms from unrelated conditions. As a result, the migraine subtype analyses involved considerably smaller sample sizes than the main analysis (6,332 case samples and 144,883 controls for migraine with aura; 8,348 case samples and 139,622 controls for migraine without aura; Table 1 ).
As with the primary analysis, the test statistics for migraine with aura and for migraine without aura were consistent with underlying polygenic architecture rather than other potential sources of inflation ( Supplementary Figs. 7 and 8 ). In our analysis for migraine without aura, we found seven significantly (P < 5 × 10 −8 ) associated genomic loci (near TSPAN2, TRPM8, PHACTR1, FHL5, ASTN2, near FGF6, and LRP1; Supplementary Table 11 and Supplementary Fig. 9 ). All seven of these loci had already been identified in the primary analysis, possibly reflecting the fact that migraine without aura is the most common form of migraine (around two in three cases) and probably drove these association signals in the primary analysis. Notably, no loci were associated with migraine with aura in the other subset analysis (Supplementary Fig. 10 ).
To investigate whether excess heterogeneity could be contributing to the lack of associations for migraine with aura, we carried out a heterogeneity analysis of the two subgroups (Online Methods and Supplementary Table 12 ). We selected the 44 LD-independent SNPs from the primary analysis and used a random-effects model to combine the 'migraine with aura' and 'migraine without aura' samples in a meta-analysis that allowed for heterogeneity between the two migraine groups 58 . We found little heterogeneity, with only 7 of the 44 loci (at MEF2D, PHACTR1, near REST-SPINK2, ASTN2, PLCE1, MPPED2, and near MED14-USP9X) exhibiting signs of heterogeneity across subtype groups (Supplementary Table 13 ).
Credible sets of markers within each locus
For each of the 38 migraine-associated loci, we defined a credible set of markers that could plausibly be considered as causal using a Bayesian-likelihood-based approach 59 . This method incorporated evidence from association-test statistics and the LD structure between SNPs in a locus (Online Methods). A list of the credible set of SNPs obtained for each locus is provided in Supplementary Table 14 .
We found three loci (in RNF213, PLCE1, and MRVI1) for which the association signal could be credibly attributed to exonic mis-sense polymorphisms (Supplementary Table 15 ). However, most of the credible markers at each locus were either intronic or intergenic, which is consistent with the theory that most variants detected by GWA studies involve regulatory effects on gene expression rather than disruption of protein structure 60, 61 .
Overlap with eQTLs in specific tissues
To identify migraine loci that might influence gene expression, we used previously published data sets cataloging expression quantitative Figure 2 Expression enrichment of genes from the migraine loci in GTEx tissue samples. Expression data from 1,641 samples were obtained using RNA-seq for 42 tissues and three cell lines. Enrichment P values were assessed empirically for each tissue using a permutation procedure (100,000 replicates), and the red vertical line shows the significance threshold after adjustment for multiple testing by Bonferroni correction (Online Methods). LCL, Epstein−Barr transformed lymphoblastoid cell lines. npg A r t i c l e s trait loci (eQTLs) in either of two microarray-based studies of samples from peripheral venous blood (n = 3,754) or from human brain cortex (n = 550). Additionally, we used a third study based on RNA-seq data from a collection of 42 tissues and three cell lines (n = 1,641) from the GTEx Consortium project 62 . Although these data offered the advantage of a diverse tissue catalog, the number of samples per tissue was relatively small (Supplementary Table 16 ) compared with the two microarray data sets, which may have resulted in reduced power to detect significant eQTLs in some tissues. Using these data sets, we applied a method based on the overlap of migraine and eQTL credible sets to identify eQTLs that could explain associations at the 38 migraine loci (Online Methods). This approach merged the migraine credible sets defined above with credible sets from cis-eQTL signals within a 1-Mb window and tested whether the association signals between the migraine and eQTL credible sets were correlated. After adjusting for multiple testing, we found no plausible eQTL associations in the peripheral blood or brain cortex data (Supplementary Tables 17 and 18 and Supplementary Fig. 11 ). In the GTEx data, however, we found evidence for overlap from eQTLs in three tissues (lung, tibial artery, and aorta) at the HPSE2 locus and in one tissue (thyroid) at the HEY2-NCOA7 locus (Supplementary Table 19 and Supplementary Fig. 12 ).
In summary, from three data sets we found evidence implicating eQTL signals at only two loci (HPSE2 and HEY2). This low number (2 out of 38) is consistent with previous studies noting that available eQTL catalogs currently lack sufficient tissue specificity and developmental diversity to provide enough power for meaningful biological insight 53 . No plausibly causal eQTLs were observed in expression data from brain tissue samples.
Gene expression enrichment in specific tissues
To understand whether the 38 migraine loci as a group are enriched for expression in certain tissue types, we again used the GTEx pilot data 62 (Online Methods). We found four tissues that were significantly enriched (after Bonferroni correction) for expression of the migraine-associated genes (Fig. 2) . The two most strongly enriched tissues were part of the cardiovascular system (aorta and tibial artery). The two other significantly enriched tissues were from the digestive system (esophagus muscularis and esophageal mucosa). We replicated these enrichment results using the DEPICT 63 tool and an independent microarray-based gene expression data set (Online Methods). DEPICT highlighted four tissues (Fig. 3 and Supplementary Table 20 ) with significant enrichment of genes within the migraine loci: arteries (P = 1.58 × 10 −5 ), the upper gastrointestinal tract (P = 2.97 × 10 −3 ), myometrium (P = 3.03 × 10 −3 ), and stomach (P = 3.38 × 10 −3 ).
Taken together, the expression analyses implicated arterial and gastrointestinal tissues. To discover whether this enrichment signature could be attributed to a more specific type of smooth muscle, we examined the expression of the nearest genes at migraine loci in a panel of 60 types of human smooth muscle tissue 64 . Overall, migraine loci genes were not significantly enriched in a particular class of smooth muscle (Supplementary Figs. 13-15 ). This suggests that the enrichment of migraine risk variants in genes expressed in tissues with a smooth muscle component is not specific to blood vessels, the stomach, or the gastrointestinal tract; rather, it seems to be generalizable across vascular and visceral smooth muscle types.
Combined, these enrichment results suggest that some of the genes affected by migraine-associated variants have high expression in vascular tissues, and their dysfunction could have a role in migraine. Furthermore, the results suggest that other tissue types (for example, smooth muscle) could also have a role, which may become evident once more migraine loci are discovered.
Enrichment in tissue-specific enhancers
To further assess the hypothesis that migraine variants might operate via effects on gene regulation, we investigated the degree of overlap with histone modifications. Using candidate causal variants from the migraine loci, we examined their enrichment in cell-type-specific enhancers from 56 primary human tissues and cell types from the Roadmap Epigenomics 65 and ENCODE projects 66 (Online Methods  and Supplementary Table 21 ). These variants showed the greatest enrichment in tissues from the mid-frontal lobe and duodenum smooth muscle, but their enrichment was not significant after adjustment for multiple testing (Fig. 4) .
Gene set enrichment analyses
To implicate underlying biological pathways involved in migraine, we applied a Gene Ontology over-representation analysis of the 38 migraine loci (Online Methods). We found nine vascular-related biological function categories that were significantly enriched (adjusted P < 0.05) after correction for multiple testing (Supplementary Table  22 ). Notably, data for the identified loci provided little statistical support for some molecular processes that have been previously linked to migraine, including ion homeostasis, glutamate signaling, serotonin signaling, NO signaling, and oxidative stress. However, a possible explanation for the lack of enrichment for these functions is that current annotations for many genes and pathways are far from comprehensive, or that larger numbers of migraine loci need to be identified before sensitivity can be sufficient to detect enrichment for these mechanisms.
For a more comprehensive pathway analysis, we used DEPICT, which incorporates gene coexpression information from microarray data to implicate additional, functionally less well-characterized genes in known biological pathways, protein-protein complexes, and mouse phenotypes 63 (by forming so-called reconstituted gene sets). From DEPICT, we identified 67 reconstituted gene sets that were A r t i c l e s significantly enriched (false discovery rate (FDR) < 5%) for genes found among the migraine-associated loci (Supplementary Table 23 ). Because the reconstituted gene sets had genes in common, we clustered them into ten distinct groups ( Fig. 5 and Online Methods). Several gene sets, including the most significantly enriched reconstituted gene set (abnormal vascular wound healing; P = 1.86 × 10 −6 ), were grouped into clusters related to cell-cell interactions (ITGB1 protein-protein interaction, adherens junction, and integrin complex). Several of the other gene set clusters were also related to vascular biology ( Fig. 5 and Supplementary Table 23) . We still did not observe any support for molecular processes with hypothesized links to migraine (Supplementary Table 24) ; however, this might again have been due to the reasons outlined above.
DISCUSSION
In what is to our knowledge the largest genetic study of migraine so far, we identified 38 distinct genomic loci harboring 44 independent susceptibility markers for the prevalent forms of migraine. We provide evidence that migraine-associated genes are involved in both arterial and smooth muscle function. Two separate analyses, the DEPICT and GTEx gene expression enrichment analyses, pointed to the involvement of vascular and smooth muscle tissues in common variant susceptibility to migraine. The vascular finding is consistent with known comorbidities and previously reported shared polygenic risk among migraine, stroke, and cardiovascular diseases 67, 68 . Furthermore, a recent GWA study of cervical artery dissection identified a genomewide significant association at the same index SNP (rs9349379 in the PHACTR1 locus) as is associated with migraine, suggesting the possibility of partially shared genetic components between migraine and cervical artery dissection 26 . These results suggest that vascular dysfunction and possibly also smooth muscle dysfunction are likely to have roles in migraine pathogenesis. The support for vascular and smooth muscle enrichment of the loci is strong, with multiple lines of evidence from independent methods and independent data sets. However, it remains likely that neurogenic mechanisms are also involved in migraine. For example, several lines of evidence from previous studies have pointed to such mechanisms 5,69-72 . We found some support for this in our examination of the expression of individual genes at the 38 loci ( Supplementary Fig. 3 and Supplementary Table 25 ), which showed that several genes were specifically active in brain tissues. We did not observe statistically significant enrichment in brain across all loci, but it may be that more associated loci are needed in order for this to be detected. Alternatively, the lack of significant enrichment could be due to difficulties in collecting appropriate brain tissue samples with enough specificity, or other technical 6 , it is likely that the signals observed here broadly represent smooth muscle signals rather than gastrointestinal specificity. Smooth muscle is a predominant tissue of the intestine, but specific smooth muscle subtypes were not available to test this hypothesis in our primary enrichment analyses. Instead we examined a range of 60 smooth muscle subtypes and found that the migraine loci were expressed in many types of smooth muscle, including vascular ( Supplementary Figs. 14 and 15) . These results, although not conclusive, suggest that the enrichment of the migraine loci in smooth muscle is not specific to the stomach and gastrointestinal tract.
Our results implicate cellular pathways and provide an opportunity to determine whether the genomic data support previously presented hypotheses of mechanisms linked to migraine. One prevailing hypothesis, stimulated by findings in FHM, has been that migraine is a channelopathy 5, 21 . Among the 38 migraine loci in the current study, only two harbor known ion channels (KCNK5 and TRPM8) 19, 20 , and three others (SLC24A3, near ITPK1, and near GJA1) can be linked to ion homeostasis [22] [23] [24] . This further supports the findings of previous studies that, in common forms of migraine, ion channel dysfunction is not the major pathophysiological mechanism 15 . However, more generally, genes involved in ion homeostasis could be a component of genetic susceptibility. Moreover, we cannot exclude that ion channels might still be important contributors in migraine with aura, the form most closely resembling FHM, as identifying loci for this subgroup is more challenging. Another hypothesis relates to oxidative stress and NO signaling [73] [74] [75] . Six genes with known links to oxidative stress and NO were identified in these 38 loci (REST, GJA1, YAP1, PRDM16, LRP1, and MRVI1) [45] [46] [47] [48] [49] [50] . This is in line with previous findings 11 ; however, the DEPICT pathway analysis did not show an association between NO-related reconstituted gene sets and migraine (FDR > 0.54; Supplementary Table 24) .
Notably, in the migraine-subtype analyses, it was possible to identify specific loci for migraine without aura but not for migraine with aura.
However, the heterogeneity analysis (Supplementary Tables 12  and 13 ) demonstrated that most of the identified loci were implicated in both migraine subtypes. This suggests that the absence of significant loci in the analysis for migraine with aura was mainly due to a lack of power owing to the smaller sample size. Additionally, as shown by the LD-score analysis (Supplementary Figs. 6-8) , the amount of heritability captured by the data set for migraine with aura was considerably lower than that for migraine without aura, such that in order for comparable power to be achieved, a sample size two to three times larger would be required. This might reflect a higher degree of heterogeneity in the clinical capture, more complex underlying biology, or even a greater contribution to risk from lowfrequency and rare variation for this form of the disease.
In conclusion, the 38 genomic loci identified in this study support the notion that factors in vascular and smooth muscle tissues contribute to migraine pathophysiology and that the two major subtypes of migraine-migraine with aura and migraine without aura-have a partially shared underlying genetic susceptibility profile. 
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Study design and phenotyping. A description of the study design, ascertainment, and phenotyping for each GWA study is provided in the Supplementary Note. Quality control. The 22 individual GWA studies were subjected to preestablished quality control (QC) protocols as recommended elsewhere 76, 77 . Differences in genotyping chips, DNA quality, and calling pipelines necessitated that the QC parameters be tuned separately for each study. At a minimum, we excluded markers that had high 'missingness' rates (>5%), that had low minor allele frequency (<1%), and that failed a test of Hardy-Weinberg equilibrium. We also excluded individuals with a high proportion of missing genotypes (>5%) and used identity-by-descent estimates to remove related individuals (identity by descent > 0.185). A summary of the genotyping platforms, QC, and software used in each study is provided in Supplementary  Table 3 . To control for population stratification within each study, we merged the genotypes passing QC filters with HapMap III data from three populations: European (CEU), Asian (CHB+JPT), and African (YRI). We then performed a principal-components analysis on the merged data set and excluded any (non-European) population outliers. To control for any sub-European population structure, we performed a second principal-components analysis within each study to ensure that cases and controls were clustering together. Any principal components that were significantly associated with the phenotype were included as covariates in the model when we calculated test statistics for the meta-analysis (Supplementary Table 4 ).
Imputation.
After study-level QC, estimated haplotypes were phased for each individual using (in most instances) the program SHAPEIT 78 . Missing genotypes were then imputed into these haplotypes using the program IMPUTE2 (ref. 79 ) and a mixed-population 1000 Genomes Project 16 reference panel (March 2012, phase 1, v3 release or later). A minority of contributing studies used alternative programs for phasing and imputation (BEAGLE 80 , MACH 81 , MINIMAC 82 , or in-house custom software). A summary of software and procedures used is provided in Supplementary Table 3 .
Statistical analysis. Individual-study association analyses were implemented using logistic regression with an additive model on the imputed dosage of the effect allele. All models were adjusted for sex and other relevant covariates when appropriate (Supplementary Table 4 ). Because age information was not available for all individuals from all studies, we were not able to adjust for it in our models. However, we note that all of the GWA studies included adults past the typical age of onset; thus age was at most a non-confounding factor, and false positive rates would therefore not be affected by its inclusion or exclusion. For the within-study association analyses, we used SNPTEST, PLINK, or R. The program GWAMA was then used to perform a fixed-effects meta-analysis weighted by the inverse variances to obtain a combined effect size, standard error, and P value at each marker. We excluded markers in any study that had low imputation quality scores (IMPUTE2 INFO < 0.6 or MACH r 2 < 0.6) or low minor allele frequency (MAF < 0.01). Additionally, we filtered out markers that were missing from more than half of all studies (12 or more) or that exhibited high heterogeneity (heterogeneity index I 2 > 0.75). After filtering, 8,045,569 total markers were tested in the meta-analysis.
Chromosome X meta-analysis. Because of the different ploidy of males and females on chromosome X, we implemented a model of X-chromosome inactivation that assumes an equal effect of alleles in both males and females. We achieved this by scaling male dosages to the range of 0-2 to match that of females. In total, 57,756 cases and 299,109 controls were available for the X-chromosome analysis (Supplementary Table 1 ). The sample size was smaller than that for the autosomal data because some of the individual GWA studies (EGCUT, Rotterdam III, Twins UK, and 846 controls from GSK for the German MO study) did not contribute chromosome X data.
LD-score regression analysis. We conducted a univariate heritability analysis based on summary statistics using LD-score regression (LDSC) 56 v1.0.0.
For this analysis, we extracted high-quality common SNPs from the summary statistics by filtering the data according to the following criteria: presence among the HapMap Project Phase 3 SNPs 83 , allele matching to 1000 Genomes Project data, no strand ambiguity, INFO score > 0.9, MAF ≥ 1%, and missingness less than two-thirds of the 90th percentile of the total sample size. The HLA region (chromosome 6, 25-35 Mb) was excluded from the analysis. With these data, we used LDSC to quantify the proportion of the total inflation in chi-square statistics that could be ascribed to polygenic heritability by calculating the ratio of the LDSC intercept estimate and the chi-square mean using the formula described in the original publication 56 .
Heterogeneity analysis of migraine subtypes. To determine whether heterogeneity between the migraine subtypes might have affected our ability to identify new loci, we performed an additional meta-analysis using a subtypedifferentiated approach that allows for different allelic effects between two groups 58 . Because a large proportion of the controls were shared between the original data sets for migraine with aura and migraine without aura ( Table 1) , for this analysis we created two additional subsets of the migraine subtype data that contained no overlapping controls (Supplementary Table 12 ). The new 'migraine with aura' subset consisted of 4,837 cases and 49,174 controls, and the new 'migraine without aura' subset consisted of 4,833 cases and 106,834 controls. To assess the heterogeneity observed, we chose the 44 index SNPs from the primary meta-analysis and applied the subtype-differentiated metaanalysis method to them. We observed that only 7 out of the 44 SNPs exhibited heterogeneity in the subtype-differentiated test (heterogeneity P value < 0.05; Supplementary Table 13 ), suggesting that most loci probably affect risk for both subtypes.
Defining credible sets. Within each migraine-associated locus, we defined a credible set of variants that could be considered 99% likely to contain a causal variant. The method has been described in detail elsewhere 53, 59 and is outlined briefly here. Assume D represents the data including the genotype matrix X for all of the P variants (the genotype for variant j is denoted as x j ) and disease status Y (for N individuals), and β represents the model parameters. We define the model, denoted by A, as the causal status for all of the P variants in the locus: A ≡ {a j }, in which a j is the causal status for variant j. a j = 1 if the variant j is causal, and a j = 0 if it is not. We assume that there is one and only one genuine signal for each locus; therefore, one and only one of the P variants is causal: Σ j a j = 1. For convenience, we define A j as the model in which only variant j is causal, and A 0 as the model in which no variant is causal (null model). The probability of model A j (where variant j is the only causal variant in the locus) given the data can be calculated using Bayes's rule:
We estimate equation (1) using the steepest-descent approach 84 . Making the assumption of a flat prior on the model parameters, we approximate the integral over the model parameters using their maximum likelihood estimator
where the sample size is denoted by N and the number of fitted parameters for model A j is denoted by |β j |. |β j | is a constant because model A j has the same number of parameters across all variants. In the framework of a generalized linear model, the deviance for two nested models follows an approximate chi-square distribution. We therefore define Pr(A j |D) in equation (2) is then a function of c j 2 :
We make the assumption that the prior causal probability for all variants is equal, that is, Pr(A j ) is the same across all variants j. Equation (5) , and the probability that variant j is causal can be calculated using
which can be normalized across all variants as
Finally, the 99% credible set of variants is defined as the smallest set of models, with each model designating one causal variant, S = {A j }, such that
This credible set of variants has 99% probability of containing the causal variant, given the assumption that there is a true association and that all possible causal variants have been genotyped (both assumptions are likely to be valid in genome-wide significant regions of data that have been imputed to the 1000 Genomes Project). We have made the R script for implementing the method freely available online (see "URLs").
eQTL credible set overlap analysis. To assess whether the association statistics in the 38 migraine loci could be explained by credible overlapping eQTL signals, we used two eQTL microarray data sets. The first consisted of 3,754 samples from peripheral venous blood 85 , and the second was from a meta-analysis of human brain cortex studies of a total of 550 samples 86 . From both studies, we obtained summary statistics from an association test of putative cis-eQTLs between all SNP-transcript pairs within a 1-Mb window. Then, for the most significant eQTLs (P < 1 × 10 −4 ) found for genes within a 1-Mb window of migraine credible set variants (see "Defining credible sets"), we created an additional credible set of markers for each eQTL. We then tested (using Spearman's rank correlation) whether there was a significant correlation between the association test statistics in each migraine credible set compared to the expression test statistics in each overlapping eQTL credible set. Significant correlation between a migraine credible set and an eQTL credible set was taken as evidence that the migraine locus tagged a real eQTL. An appropriate significance threshold for multiple testing was determined by Bonferroni correction.
GTEx tissue enrichment analysis. We obtained gene sets for each locus by taking all genes within 50 kb of credible-set SNPs. We then analyzed identified genes for tissue enrichment using publicly available expression data from the pilot phase of the GTEx project 62 , version 3. In this data set,
(6) (6)
(8)
postmortem samples from 42 human tissues and three cell lines across 1,641 samples ( Supplementary Table 16 ) were used for bulk RNA sequencing according to a unified protocol. All samples were sequenced using Illumina 76-base-pair paired-end reads. Collapsed reads per kilobase per million mapped reads (RPKM) for 52,577 transcripts were filtered for those with unique HGNC IDs (n = 20,932). We also excluded transcripts from any noncoding RNAs. We ranked all transcripts by mean RPKM across all samples, and we generated 100,000 permutations of each credible set gene list by selecting a random transcript for each entry in the credible set within ±100 ranks of the transcript for that gene. For each sample, the RPKM values were converted into ranks for that transcript, and sums of ranks within each tissue were computed for each gene. We calculated enrichment P values for each tissue by taking the total number of instances when the gene list of interest had a lower sum of ranks than the permuted sum of ranks (divided by the total number of permutations). We estimated the number of independent tissues using the matSpD tool 87 and then used Bonferroni correction to adjust for 27 independent tests (P < 1.90 × 10 −3 ).
Specificity of individual genes in GTEx tissues.
We selected the nearest gene to the index SNP at each migraine locus and then investigated the individual expression activity of each of the selected genes. Because the number of samples for some tissues was small, we grouped individual tissues into four categories: brain, vascular, gastrointestinal, and other tissues (Supplementary Table 16 ).
For each selected gene, we then tested whether the average expression (mean RPKM) was significantly higher in a particular tissue group compared with the 'other tissues' category. We assessed significance using a one-tailed t-test and used Bonferroni correction to adjust for 114 tests (38 genes × 3 tissue groups). Although some genes were observed to be significantly expressed in multiple tissue groups, we determined that a gene was tissue specific if it had high expression in only one tissue group (i.e., brain, vascular, or gastrointestinal; Supplementary Table 25) .
eQTL credible set analysis in GTEx tissues. For all tissues and transcripts (filtered as described above), we identified genome-wide significant (P < 2 × 10 −13 ) cis-eQTLs within a 1-Mb window of each transcript and created credible sets (see "Defining credible sets") for each eQTL identified in each tissue. We found a total of 35 of these significant eQTL credible sets within a 1-Mb window of the migraine loci; however, only 7 out of the 35 contained variants that overlapped with a migraine credible set. For these seven eQTL credible sets, we then tested (using Spearman's rank correlation) whether the test statistics between the two overlapping credible sets were significantly correlated. Significant correlation between a migraine credible set and an eQTL credible set was taken as evidence that the migraine locus tagged a real eQTL. Multiple testing was controlled for the use of Bonferroni correction (i.e., for seven tests at P < 7.1 × 10 −3 ).
Enhancer enrichment analysis. Markers of gene regulation were defined using ChIP-seq data sets from ENCODE 66 and the NIH Roadmap Epigenome 65 projects. On the basis of the histone H3K27ac signal, which identifies active enhancers, we processed data from 56 cell lines and tissue samples to identify cell-type-specific and tissue-specific enhancers, which we define as the 10% of enhancers with the highest ratio of reads in that cell or tissue type divided by the total reads 88 . The raw data are publicly available (see "URLs"), and a description of the 56 tissues and cell types is provided in Supplementary  Table 21 . We mapped the credible set variants at each migraine locus to these enhancer sites and compared the overlap observed with tissue-specific enhancers relative to a background of 10,000 randomly selected sets of SNPs of equal size. We restricted the background selection to 1000 Genomes Project variants (MAF > 1%) that also passed QC filters in the meta-analysis (to allow the selection of only SNPs that had an a priori chance of being associated). The selection procedure then involved randomly selecting genomic regions with length and density of enhancers equivalent to those found in the original locus. Once an appropriate region was found, a set of SNPs was randomly selected to match the number of SNPs in the credible set for that locus. If the selected SNPs mapped to an equal number of enhancer sites (of any tissue type) as credible SNPs from the original locus, then they were added to the background set of SNPs for comparison. If the selected SNPs did not map to the correct number of enhancers, the selection procedure was repeated until an appropriate set was found. This procedure was repeated 10,000 times for each locus to obtain an empirical null distribution. We then estimated the enrichment significance empirically by calculating the proportion of replicates that were greater than the observed value. Finally, we used Bonferroni correction to adjust for multiple testing of 56 tissue and cell types (P < 8.9 × 10 −4 ).
GO enrichment analysis.
The set of 38 genes nearest to the index SNP in each migraine locus was chosen and tested for over-representation in Gene Ontology (GO) annotations. We used the PANTHER 89 tool (see "URLs") to perform the analysis, implementing a binomial test to determine whether the number of genes from the migraine test set found in each GO pathway was likely to have occurred by chance alone. The association P values were adjusted for the number of pathways tested by Bonferroni correction.
DEPICT reconstituted gene set enrichment analysis. DEPICT 63 (Data-driven Expression Prioritized Integration for Complex Traits) is a computational tool that, given a set of GWA study summary statistics, allows prioritization of genes in associated loci, enrichment analysis of reconstituted gene sets, and tissue enrichment analysis. DEPICT was run using 124 independent genomewide significant SNPs as input (PLINK clumping parameters: --clump-p1 5e-8 --clump-p2 1e-5 --clump-r2 0.6 --clump-kb 250; note that rs12845494 and rs140002913 could not be mapped). LD distance (r 2 > 0. After the analysis, we omitted reconstituted gene sets in which genes in the original gene set were not nominally enriched (Wilcoxon rank-sum test) because, by design, genes in the original gene set were expected to be enriched in the reconstituted gene set. Therefore, a lack of enrichment complicated interpretation because the label of the reconstituted gene set may have been inaccurate. Hence eight reconstituted gene sets were removed from the results: MP:0002089, MP:0002190, ENSG00000151577, ENSG00000168615, ENSG00000143322, ENSG00000112531, ENSG00000161021, and ENSG00000100320. We also removed an association identified for another gene set (ENSG00000056345 PPI, P = 1.7 × 10 −4 , FDR = 0.04) because it was no longer part of the Ensembl database. Finally, we used the Affinity Propagation tool 91 to cluster related reconstituted gene sets into ten groups (see "URLs").
DEPICT tissue enrichment analysis. DEPICT used data from 37,427 human microarray samples captured on the Affymetrix HGU133a2.0 platform to test whether genes in the 38 migraine loci were highly expressed in 209 tissues and cell types with Medical Subject Heading (MeSH) annotations. The annotation procedure and method for normalizing expression profiles across annotations is outlined in the original publication 63 . The tissue/cell-type enrichment analysis algorithm was conceptually identical to the gene set enrichment analysis whereby enrichment P values were calculated empirically using 500 permutations for bias adjustment and 20 replications for FDR estimation.
Data access. All genome-wide significant and suggestive SNP associations (P < 1 × 10 −5 ) from the meta-analysis can be obtained directly from the IHGC website (http://www.headachegenetics.org/content/datasets-and-cohorts). For access to deeper-level data, please contact the data access committee (fimm-dac@helsinki.fi).
